Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
|
|
NANOVIRICIDES, INC. (NNVC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
10-K
| Annual Report for the period ended June 30, 2023 |
| 09/28/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 05/25/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/23/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/08/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 05/05/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 03/31/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data|
Docs:
|
"LICENSE AGREEMENT THIS LICENSE AGREEMENT is made at Kolhapur on March 10, 2023 by and Between NANOVIRICIDES, INC. a Company incorporated under the laws of the State of Nevada, and having its registered office at 1 Controls Drive, Shelton, CT 06484 and its successors and assigns with offices And M/S KARVEER MEDITECH PRIVATE LIMITED a company incorporated under Companies Act, 2013 and having it registered office at plot No. 34, Vijaya Nagar, Near Shahu Naka, Ujalaiwadi, Kolhapur, Taluka-Karveer, District-Kolhapur, Maharashtra, India 416004 and its successors and assigns and all of whom are at times referred to as the "Parties". WHEREAS, Karveer is engaged in conducting research and development in the fields of pharmaceuticals and related activities, and has the necessary skill, experience, e..." |
|
| 02/14/2023 |
10-Q
| Quarterly Report for the period ended December 31, 2022 |
| 02/13/2023 |
8-K
| Quarterly results |
| 12/22/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/22/2022 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events Interactive Data |
| 11/15/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/04/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 10/13/2022 |
10-K
| Annual Report for the period ended June 30, 2022 |
| 10/11/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"EXTENSION TO EMPLOYMENT AGREEMENT This Extension to Employment Agreement effective as of July 1, 2022, between ANIL R. DIWAN, c/o NanoViricides, Inc., 1 Controls Drive, Shelton, CT 06484 , and NanoViricides, Inc., a corporation with offices at 1 Controls Drive, Shelton, CT 06484 . WHEREAS, the Parties entered into that certain Employment Agreement on July 11, 2018 which expired pursuant to its terms on June 30, 2021 which was subsequently extended to June 30, 2022 ; WHEREAS, the parties hereto desire to extend the term of the Employment Agreement and to add to and/or revise the terms and conditions of the Employment Agreement; and WHEREAS, the Parties hereto desire that all other terms and conditions of the Employment Agreement not specifically amended hereby will remain in full force and ..." |
|
| 09/29/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 08/10/2022 |
4
| Diwan Anil (President) has filed a Form 4 on NANOVIRICIDES, INC.|
Txns:
| Gifted 94,471 shares
@ $0 |
|
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 02/14/2022 |
10-Q
| Quarterly Report for the period ended December 31, 2021 |
| 11/26/2021 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 10/12/2021 |
10-K
| Annual Report for the period ended June 30, 2021 |
| 10/12/2021 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 09/28/2021 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 09/21/2021 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 09/15/2021 |
8-K
| Quarterly results |
| 05/14/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 02/16/2021 |
10-Q
| Quarterly Report for the period ended December 31, 2020 |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/26/2021 |
SC 13G/A
| Empery Asset Management, LP reports a 0% stake in NanoViricides, Inc. |
| 01/04/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/10/2020 |
8-K
| Submission of Matters to a Vote of Security Holders |
|
|
|